NeuPath Net Income vs End Period Cash Flow Analysis

NPTH Stock

CAD 0.17 0.01 6.25%

NeuPath Health financial indicator trend analysis is infinitely more than just investigating NeuPath Health recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuPath Health is a good investment. Please check the relationship between NeuPath Health Net Income and its End Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuPath Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Net Income vs End Period Cash Flow

Net Income vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuPath Health Net Income account and End Period Cash Flow. At this time, the significance of the direction appears to have very week relationship.

The correlation between NeuPath Health's Net Income and End Period Cash Flow is 0.28. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of NeuPath Health, assuming nothing else is changed. The correlation between historical values of NeuPath Health's Net Income and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of NeuPath Health are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Net Income i.e., NeuPath Health's Net Income and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.28

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in NeuPath Health financial statement analysis. It represents the amount of money remaining after all of NeuPath Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

End Period Cash Flow

Most indicators from NeuPath Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuPath Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuPath Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

At this time, NeuPath Health's Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 9.9 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 7.3 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	11.1M	10.8M	12.3M	11.9M
Total Revenue	60.9M	62.7M	66.1M	63.1M

Gross Profit Total Revenue

NeuPath Health fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Other Current Assets	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Total Liab
Other Current Liab		-0.47	0.76	-0.88	0.96	-0.92	-0.8	-0.84	-0.5	-0.81	-0.95	-0.87	-0.88	-0.96	-0.6	0.97	-0.67	-0.63	-0.67	-0.68	0.73	-0.8	-0.97	-0.15	-0.61	0.91
Total Current Liabilities	-0.47		-0.34	0.18	-0.65	0.7	0.87	0.66	0.83	0.42	0.49	0.65	0.47	0.41	0.44	-0.39	0.22	0.45	0.39	0.28	-0.45	0.28	0.39	0.17	0.43	-0.31
Other Liab	0.76	-0.34		-0.71	0.81	-0.74	-0.71	-0.78	-0.35	-0.68	-0.76	-0.77	-0.64	-0.75	-0.39	0.76	-0.52	-0.41	-0.5	-0.53	0.61	-0.64	-0.78	0.0	-0.39	0.78
Net Tangible Assets	-0.88	0.18	-0.71		-0.75	0.7	0.56	0.74	0.42	0.93	0.83	0.65	0.85	0.96	0.33	-0.94	0.89	0.38	0.35	0.37	-0.58	0.53	0.81	-0.09	0.34	-0.87
Retained Earnings	0.96	-0.65	0.81	-0.75		-0.97	-0.92	-0.89	-0.6	-0.75	-0.94	-0.94	-0.83	-0.89	-0.64	0.91	-0.55	-0.67	-0.72	-0.71	0.73	-0.81	-0.95	-0.21	-0.65	0.85
Accounts Payable	-0.92	0.7	-0.74	0.7	-0.97		0.94	0.91	0.58	0.71	0.95	0.97	0.79	0.85	0.7	-0.87	0.49	0.69	0.77	0.75	-0.7	0.74	0.91	0.19	0.7	-0.72
Net Receivables	-0.8	0.87	-0.71	0.56	-0.92	0.94		0.89	0.78	0.69	0.84	0.92	0.7	0.74	0.53	-0.76	0.49	0.55	0.58	0.57	-0.58	0.62	0.77	0.15	0.54	-0.67
Other Current Assets	-0.84	0.66	-0.78	0.74	-0.89	0.91	0.89		0.64	0.83	0.87	0.92	0.87	0.86	0.62	-0.86	0.65	0.65	0.58	0.54	-0.57	0.6	0.8	0.26	0.65	-0.66
Other Stockholder Equity	-0.5	0.83	-0.35	0.42	-0.6	0.58	0.78	0.64		0.69	0.49	0.53	0.53	0.56	0.07	-0.51	0.63	0.15	0.01	-0.01	-0.29	0.19	0.37	-0.05	0.09	-0.52
Total Current Assets	-0.81	0.42	-0.68	0.93	-0.75	0.71	0.69	0.83	0.69		0.78	0.66	0.86	0.94	0.26	-0.89	0.95	0.32	0.21	0.2	-0.51	0.39	0.7	-0.1	0.28	-0.8
Common Stock	-0.95	0.49	-0.76	0.83	-0.94	0.95	0.84	0.87	0.49	0.78		0.94	0.79	0.91	0.57	-0.96	0.63	0.57	0.68	0.75	-0.58	0.79	0.96	0.12	0.59	-0.81
Property Plant Equipment	-0.87	0.65	-0.77	0.65	-0.94	0.97	0.92	0.92	0.53	0.66	0.94		0.73	0.8	0.66	-0.85	0.45	0.66	0.75	0.8	-0.54	0.8	0.9	0.28	0.68	-0.68
Total Assets	-0.88	0.47	-0.64	0.85	-0.83	0.79	0.7	0.87	0.53	0.86	0.79	0.73		0.93	0.67	-0.89	0.72	0.74	0.56	0.44	-0.72	0.57	0.81	0.31	0.69	-0.74
Total Stockholder Equity	-0.96	0.41	-0.75	0.96	-0.89	0.85	0.74	0.86	0.56	0.94	0.91	0.8	0.93		0.49	-0.99	0.83	0.54	0.5	0.5	-0.65	0.65	0.9	0.08	0.51	-0.89
Property Plant And Equipment Net	-0.6	0.44	-0.39	0.33	-0.64	0.7	0.53	0.62	0.07	0.26	0.57	0.66	0.67	0.49		-0.51	0.0	0.98	0.93	0.73	-0.68	0.58	0.64	0.61	0.99	-0.25
Net Debt	0.97	-0.39	0.76	-0.94	0.91	-0.87	-0.76	-0.86	-0.51	-0.89	-0.96	-0.85	-0.89	-0.99	-0.51		-0.78	-0.56	-0.56	-0.61	0.6	-0.75	-0.94	-0.14	-0.54	0.89
Cash	-0.67	0.22	-0.52	0.89	-0.55	0.49	0.49	0.65	0.63	0.95	0.63	0.45	0.72	0.83	0.0	-0.78		0.08	-0.05	-0.01	-0.3	0.24	0.54	-0.22	0.03	-0.74
Non Current Assets Total	-0.63	0.45	-0.41	0.38	-0.67	0.69	0.55	0.65	0.15	0.32	0.57	0.66	0.74	0.54	0.98	-0.56	0.08		0.88	0.7	-0.67	0.63	0.66	0.71	0.99	-0.33
Non Currrent Assets Other	-0.67	0.39	-0.5	0.35	-0.72	0.77	0.58	0.58	0.01	0.21	0.68	0.75	0.56	0.5	0.93	-0.56	-0.05	0.88		0.92	-0.68	0.76	0.76	0.48	0.91	-0.38
Other Assets	-0.68	0.28	-0.53	0.37	-0.71	0.75	0.57	0.54	-0.01	0.2	0.75	0.8	0.44	0.5	0.73	-0.61	-0.01	0.7	0.92		-0.44	0.9	0.82	0.45	0.76	-0.46
Long Term Debt	0.73	-0.45	0.61	-0.58	0.73	-0.7	-0.58	-0.57	-0.29	-0.51	-0.58	-0.54	-0.72	-0.65	-0.68	0.6	-0.3	-0.67	-0.68	-0.44		-0.43	-0.66	-0.01	-0.61	0.62
Good Will	-0.8	0.28	-0.64	0.53	-0.81	0.74	0.62	0.6	0.19	0.39	0.79	0.8	0.57	0.65	0.58	-0.75	0.24	0.63	0.76	0.9	-0.43		0.9	0.48	0.64	-0.71
Common Stock Shares Outstanding	-0.97	0.39	-0.78	0.81	-0.95	0.91	0.77	0.8	0.37	0.7	0.96	0.9	0.81	0.9	0.64	-0.94	0.54	0.66	0.76	0.82	-0.66	0.9		0.24	0.66	-0.86
Non Current Liabilities Total	-0.15	0.17	0.0	-0.09	-0.21	0.19	0.15	0.26	-0.05	-0.1	0.12	0.28	0.31	0.08	0.61	-0.14	-0.22	0.71	0.48	0.45	-0.01	0.48	0.24		0.7	0.06
Capital Lease Obligations	-0.61	0.43	-0.39	0.34	-0.65	0.7	0.54	0.65	0.09	0.28	0.59	0.68	0.69	0.51	0.99	-0.54	0.03	0.99	0.91	0.76	-0.61	0.64	0.66	0.7		-0.28
Total Liab	0.91	-0.31	0.78	-0.87	0.85	-0.72	-0.67	-0.66	-0.52	-0.8	-0.81	-0.68	-0.74	-0.89	-0.25	0.89	-0.74	-0.33	-0.38	-0.46	0.62	-0.71	-0.86	0.06	-0.28

Click cells to compare fundamentals

NeuPath Health Account Relationship Matchups

NeuPath Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	1.7M	1.9M	611K	432K	388.8K	369.4K
Total Current Liabilities	18.0M	10.0M	13.7M	13.9M	9.1M	13.7M
Other Liab	96K	59K	215K	33K	29.7K	28.2K
Net Tangible Assets	(10.9M)	7.8M	2.1M	63K	72.5K	76.1K
Retained Earnings	(13.5M)	(18.5M)	(21.8M)	(25.9M)	(26.0M)	(27.3M)
Accounts Payable	5.2M	5.6M	7.5M	8.8M	7.5M	6.5M
Net Receivables	7.2M	5.9M	6.6M	7.0M	6.7M	6.5M
Other Current Assets	614K	634K	988K	670K	606K	592.6K
Other Stockholder Equity	11.7M	12.9M	9.2M	4.9M	5.6M	9.7M
Total Current Assets	8.6M	19.3M	15.4M	11.1M	10.7M	12.4M
Common Stock	11.5M	32.8M	36.8M	39.9M	45.9M	24.6M
Property Plant Equipment	8.2M	6.6M	11.6M	11.5M	13.3M	8.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC